S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
Log in
NASDAQ:OMCL

Omnicell Stock Forecast, Price & News

$70.71
+0.55 (+0.78 %)
(As of 09/24/2020 04:44 PM ET)
Add
Compare
Today's Range
$70.15
Now: $70.71
$72.13
50-Day Range
$66.68
MA: $70.22
$77.12
52-Week Range
$54.24
Now: $70.71
$94.85
Volume3.02 million shs
Average Volume329,545 shs
Market Capitalization$3.02 billion
P/E Ratio62.58
Dividend YieldN/A
Beta0.93
Omnicell, Inc. provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides automated dispensing cabinets for medications and supplies used in nursing units, operating rooms, and emergency departments; analytics software to monitor drug diversion and address inventory management issues; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems used in hospitals and retail pharmacies for handling the stocking and retrieval of boxed medications. The Medication Adherence segment provides medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings; automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; and semi-automated filling equipment for the long-term care institutional pharmacy. It also offers Omnicell Patient Engagement, a subscription-based software system; patient communication tools, such as interactive voice response for pharmacies; and electronic Medication Administration Record software for use in nursing homes. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.
Read More
Omnicell logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars


Industry, Sector and Symbol

Industry Electronic computers
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:OMCL
CUSIP68213N10
Phone650-251-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$897.03 million
Cash Flow$3.76 per share
Book Value$20.16 per share

Profitability

Net Income$61.34 million

Miscellaneous

Employees2,700
Market Cap$3.02 billion
Next Earnings Date10/22/2020 (Estimated)
OptionableOptionable
$70.71
+0.55 (+0.78 %)
(As of 09/24/2020 04:44 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OMCL News and Ratings via Email

Sign-up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Omnicell (NASDAQ:OMCL) Frequently Asked Questions

How has Omnicell's stock been impacted by COVID-19?

Omnicell's stock was trading at $77.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, OMCL stock has decreased by 8.7% and is now trading at $70.71.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Omnicell?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Omnicell
.

When is Omnicell's next earnings date?

Omnicell is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Omnicell
.

How were Omnicell's earnings last quarter?

Omnicell, Inc. (NASDAQ:OMCL) announced its earnings results on Tuesday, July, 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.14. The business earned $199.62 million during the quarter, compared to the consensus estimate of $182.16 million. Omnicell had a return on equity of 9.21% and a net margin of 5.42%. The business's revenue for the quarter was down 8.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.67 earnings per share.
View Omnicell's earnings history
.

What guidance has Omnicell issued on next quarter's earnings?

Omnicell issued an update on its third quarter earnings guidance on Tuesday, July, 28th. The company provided earnings per share (EPS) guidance of $0.44-0.52 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.55. The company issued revenue guidance of $204-212 million, compared to the consensus revenue estimate of $210.78 million.

What price target have analysts set for OMCL?

8 equities research analysts have issued 12 month price targets for Omnicell's stock. Their forecasts range from $70.00 to $100.00. On average, they anticipate Omnicell's share price to reach $85.50 in the next twelve months. This suggests a possible upside of 20.9% from the stock's current price.
View analysts' price targets for Omnicell
.

Who are some of Omnicell's key competitors?

What other stocks do shareholders of Omnicell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Adobe (ADBE), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Alibaba Group (BABA) and Intel (INTC).

Who are Omnicell's key executives?

Omnicell's management team includes the following people:
  • Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO (Age 62)
  • Mr. Peter J. Kuipers, Exec. VP & CFO (Age 47)
  • Mr. Daniel S. Johnston, Exec. VP, Chief Legal & Admin. Officer and Corp. Sec. (Age 55)
  • Mr. Joseph Brian Spears, VP of Corp. Fin. & Chief Accounting Officer (Age 59)
  • Mr. Nhat H. Ngo, Exec. VP of Marketing, Strategy & Bus. Devel. (Age 46)

What is Omnicell's stock symbol?

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Who are Omnicell's major shareholders?

Omnicell's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.74%), Conestoga Capital Advisors LLC (3.53%), Bank of New York Mellon Corp (2.09%), Rockefeller Capital Management L.P. (1.07%), Goldman Sachs Group Inc. (0.89%) and Principal Financial Group Inc. (0.76%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann.
View institutional ownership trends for Omnicell
.

Which major investors are selling Omnicell stock?

OMCL stock was sold by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Tygh Capital Management Inc., Oak Ridge Investments LLC, Bank of America Corp DE, Redwood Investments LLC, Goldman Sachs Group Inc., Russell Investments Group Ltd., and Alberta Investment Management Corp. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Joanne B Bauer, Peter J Kuipers, Randall A Lipps, and Scott Peter Seidelmann.
View insider buying and selling activity for Omnicell
.

Which major investors are buying Omnicell stock?

OMCL stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, FMR LLC, Scout Investments Inc., Nordea Investment Management AB, Trillium Asset Management LLC, GAM Holding AG, Tributary Capital Management LLC, and Vident Investment Advisory LLC.
View insider buying and selling activity for Omnicell
.

How do I buy shares of Omnicell?

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Omnicell's stock price today?

One share of OMCL stock can currently be purchased for approximately $70.71.

How big of a company is Omnicell?

Omnicell has a market capitalization of $3.02 billion and generates $897.03 million in revenue each year. The company earns $61.34 million in net income (profit) each year or $2.19 on an earnings per share basis. Omnicell employs 2,700 workers across the globe.

What is Omnicell's official website?

The official website for Omnicell is www.omnicell.com.

How can I contact Omnicell?

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.